Jin-Ho Park

Jin-Ho Park

Auto-generated profile, based on publicly available information

Jin-Ho Park

Department of Family Medicine, Seoul National University Hospital, Seoul, Republic of Korea

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
JXJingyuan Xie
Jingyuan Xie
LLLili Liu
Lili Liu
NMNikol Mladkova
Nikol Mladkova
YLYifu Li
Yifu Li
HRHong Ren
Hong Ren
KKKrzysztof Kiryluk
Krzysztof Kiryluk
Membranous Nephropathy (MN) is a rare autoimmune cause of kidney failure. Here we report a genome-wide association study (GWAS) for primary MN in 3,782 cases and 9,038 controls of East Asian and European ancestries. We discover two previously unreported loci, NFKB1 (rs230540, OR = 1.25, P = 3.4 × 10−12) and IRF4 (rs9405192, OR = 1.29, P = 1.4 × 10−14), fine-map the PLA2R1 locus (rs17831251, OR = 2.25, P = 4.7 × 10−103) and report ancestry-specific effects of three classical HLA alleles: DRB1*1501 in East Asians (OR = 3.81, P = 2.0 × 10−49), DQA1*0501 in Europeans (OR = 2.88, P = 5.7 × 10−93), and DRB1*0301 in both ethnicities (OR = 3.50, P = 9.2 × 10−23 and OR = 3.39, P = 5.2 × 10−82, respectively). GWAS loci explain 32% of disease risk in East Asians and 25% in Europeans, and correctly re-classify 20–37% of the cases in validation cohorts that are antibody-negative by the serum anti-PLA2R ELISA diagnostic test. Our findings highlight an unusual genetic architecture of MN, with four loci and their interactions accounting for nearly one-third of the disease risk.

19 June 2023 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
KKKrzysztof Kiryluk
Krzysztof Kiryluk
ESElena Sanchez-Rodriguez
Elena Sanchez-Rodriguez
XZXu-Jie Zhou
Xu-Jie Zhou
FZFrancesca Zanoni
Francesca Zanoni
LLLili Liu
Lili Liu
AGAli G. Gharavi
Ali G. Gharavi

12 June 2012 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
SKSunmi Kim
Sunmi Kim
HKHyuktae Kwon
Hyuktae Kwon
JPJin-Ho Park
Jin-Ho Park
BCBelong Cho
Belong Cho
DKDonghee Kim
Donghee Kim
HCHo-Chun Choi
Ho-Chun Choi
Background: The association between low serum testosterone levels, visceral adipose tissue (VAT), and metabolic syndrome is now well known. However, the relationship between hepatic steatosis and serum testosterone levels has not been extensively studied. Our aim was to investigate the association of serum total testosterone levels with nonalcoholic fatty liver disease (NAFLD), adjusting for the influence of VAT and insulin resistance. Methods: This study is a retrospective observational cross-sectional one of healthy Korean men and was conducted at the Seoul National University Hospital Healthcare System Gangnam Center. We used data obtained from 495 men who were at least 20 years of age and who had undergone blood testing, abdominal computed tomography, and ultrasonography. Multiple logistic regression analysis was used to explore the association of serum total testosterone levels with NAFLD. Results: Men in the low serum testosterone quintile were at a higher risk for NAFLD than men in the highest serum testosterone quintile. After adjusting for age, smoking, diabetes, exercise, BMI, triglycerides, and high-density-lipoprotein cholesterol, subjects with serum testosterone levels in the lowest quintile had an odds ratio (OR) (95% confidence interval (CI)) of 5.12 (2.43–10.77) for NAFLD (p value, 0.0004). The inverse association between serum testosterone and NAFLD was attenuated by further adjustment for variables including VAT; however, it remained statistically significant (OR (95% CI): 4.52 (2.09–9.80) in the lowest quintile; p value=0.004). Conclusions: A low serum total testosterone level was independently associated with NAFLD. This report is the first one suggesting the association remains unchanged even after controlling for VAT and insulin resistance.

22 February 2021 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
PDF file
HKHyuktae Kwon
Hyuktae Kwon
JYJae Moon Yun
Jae Moon Yun
JPJin Ho Park
Jin Ho Park
BCBelong Cho
Belong Cho
KHKyungdo Han
Kyungdo Han
SCSu Hwan Cho
Su Hwan Cho
Background: Few studies have evaluated the association between being underweight and having cardiovascular disease in the general population. We investigated the incidence of stroke, myocardial infarction (MI), and all‐cause mortality according to detailed underweight categories in a large population cohort.Methods: We included 4 164 364 individuals who underwent a health examination that was conducted as part of the Korean National Health Insurance Service between January 2009 and December 2012 and followed them up to determine the incidence of stroke, MI, and all‐cause mortality until 31 December 2016. Based on the body mass index, the study population was categorized into normal (18.50–22.99), mild (17.00–18.49), moderate (16.00–16.99), and severe underweight (<16.00) groups. Cox proportional hazards analyses were performed to calculate the hazard ratio for stroke, MI, and mortality according to the severity of underweight in reference to the normal weight. We adjusted for age, sex, lifestyle, economic status, co‐morbidity, blood pressure, glucose, lipid level, and waist circumference.Results: The mean age of the 4 164 364 eligible subjects in this study cohort was 44.4 ± 14.3 years, and 46.1% of the participants were male; 46 728 strokes, 30 074 MIs, and 121 080 deaths occurred during 27 449 902 person‐years. The incidence of stroke, MI, and all‐cause mortality increased proportionally with the severity of underweight in the multivariate model. This proportional association became more evident when the waist circumference was additionally adjusted. The respective hazard ratios (95% confidence intervals) for mild, moderate, and severe underweight were 1.10 (1.06–1.15), 1.11 (1.02–1.20), and 1.38 (1.24–1.53) for stroke; 1.19 (1.14–1.25), 1.40 (1.27–1.53), and 1.86 (1.64–2.11) for MI; and 1.63 (1.60–1.67), 2.10 (2.02–2.17), and 2.98 (2.85–3.11) for all‐cause mortality. In stratified analyses based on waist circumference, the severity of underweight was consistently associated with a higher risk of stroke, MI, and death.Conclusions: The severity of underweight was associated with a higher risk of stroke, MI, and all‐cause mortality.

6 May 2020 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
KNKi-Woong Nam
Ki-Woong Nam
HKHyung-Min Kwon
Hyung-Min Kwon
HJHan-Yeong Jeong
Han-Yeong Jeong
JPJin-Ho Park
Jin-Ho Park
HKHyuktae Kwon
Hyuktae Kwon
SJSu-Min Jeong
Su-Min Jeong
Background: The triglyceride-glucose (TyG) index is a marker of insulin resistance (IR) and has been associated with various metabolic syndromes, cardiovascular diseases, and cerebrovascular diseases. However, limited information is available regarding its association with subclinical cerebral small vessel disease (cSVD). In this study, we evaluated the relationship between the TyG index and cSVD, including silent brain infarcts (SBIs) and white matter hyperintensity (WMH). Methods: We assessed health check-up participants aged 40–79 years from 2006 to 2013. The TyG index was calculated using the log scale of fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2. The Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) was also calculated. This was compared with two insulin surrogates and cSVD as another IR indicator and compared the association between two insulin surrogates and cSVD. SBI was measured for both prevalence and burden. The WMH volume was quantitatively rated using a computer-assisted semi-automated technique. Results: A total of 2615 participants were evaluated (median age: 56 years, male sex: 53%). In the multivariable logistic regression analysis, the TyG index was seen to be associated with SBI prevalence (adjusted odds ratio: 1.39; 95% confidence interval [CI] = 1.06–1.81). Further quantitative analyses showed a positive dose–response relationship between the TyG index and SBI burden (P for trend = 0.006). In multivariable linear regression analysis, the TyG index was also found to be related to the volume of WMH (β = 0.084; 95% CI = 0.013 to 0.154). Additionally, the TyG index showed a similar or slightly stronger association with the prevalence of SBI and the volume of WMH than did HOMA-IR. Conclusions: A high TyG index was associated with a higher prevalence and burden of cSVD in a neurologically healthy population. This marker of IR could be a convenient and useful predictor of cSVD.

22 January 2019 in Neurology
Verified
Journal Article
Closed access
PDF file
KNKi-Woong Nam
Ki-Woong Nam
HKHyung-Min Kwon
Hyung-Min Kwon
HJHan-Yeong Jeong
Han-Yeong Jeong
JPJin-Ho Park
Jin-Ho Park
HKHyuktae Kwon
Hyuktae Kwon
SJSu-Min Jeong
Su-Min Jeong
Objective To evaluate the relationship between serum total homocysteine (tHcy) levels and cerebral small vessel disease (cSVD) in a healthy population. Methods We included consecutive participants who visited our department for health checkups between 2006 and 2013. We rated white matter hyperintensity volumes using both the Fazekas score and semiautomated quantitative methods. We also evaluated lacunes, cerebral microbleeds, and enlarged perivascular spaces (EPVS), which are involved in cSVD. To assess the dose-dependent relationship between tHcy and cSVD parameters, we scored the burdens of each radiologic marker of cSVD. Results A total of 1,578 participants were included (age 55 ± 8 years, male sex 57%). In the multivariable analysis, tHcy remained an independent predictor of the white matter hyperintensity volume (B = 0.209; 95% confidence interval [CI] = 0.033–0.385, p = 0.020), presence of cerebral microbleeds (adjusted odds ratio = 2.800; 95% CI = 1.104–7.105, p = 0.030), and moderate to severe EPVS (adjusted odds ratio = 5.906; 95% CI = 3.523–9.901, p < 0.001) after adjusting for confounders. Furthermore, tHcy had positive associations with periventricular Fazekas score (p = 0.001, p for trend <0.001), subcortical Fazekas score (p = 0.003, p for trend = 0.005), and moderate to severe EPVS lesion burden (p < 0.001, p for trend <0.001) in a dose-dependent manner. Conclusions Serum tHcy level is correlated with cSVD development in a dose-dependent manner. These findings provide us with clues for further studies of the pathophysiology of cSVD.